Health Condition 1: null- Patients Suffering From Cervical Spondylosis (Greevagraha)
Conditions
Interventions
Intervention1: Clinical Evaluation of Panchamrit Lauha Guggulu and Panchguna Taila in the management of Cervical Spondylosis(Greeva Graha): 1. Panchamrit Lauha Guggulu (The Ayurvedic Formulary of Indi
Sponsors
Ceneral Council For Research In Ayurvedic SciencesCCRAS
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either sex with age between 30 and 60 years. 2.MRI Neck, findings suggestive of degenerative changes & cervical spondylosis. 3.Patients with or without radiculopathy. 4.Intermittent neck and shoulder pain. 5.Restricted movement of neck.
Exclusion criteria
Exclusion criteria: 1.Age below 30 years and above 60 years 2.Patients with cervical myelopathy. 3.Patients with neck pain and other degenerative signs due to other reasons like spondylolysthesis, cervical spinal stenosis, diseases of atlanto-occipital joint, meningitis, atlantoaxial joint, muscle strain or soft tissue etiology, pregnancy, tumours, internal bleeding(haematoma)infection, injury, Pottâ??s disease etc. 4.Patients with congenital cervical rib and acquired Spinal deformity(Pottâ??s fracture, compression fracture etc) 5.Patients with poorly controlled Hypertension ( >160/100 mmHg) 6. Patients with uncontrolled Diabetes Mellitus having Hb A1C of > 8% 7.Patients on medication with corticosteroids, phototherapy, biologics, antidepressants any other drugs that may have an influence on the outcome of the study. 8.Known cases of cardiovascular diseases, hepatic disorders, Renal Disorders, Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), Malignancy or any other condition that may jeopardize the study. 9. Alcoholics and/or drug abusers/ chain smokers. 10.Chronic Rheumatological and auto-immune diseases like RA, Psoriatic arthropathy, Gout, SLE. 11. H/o hypersensitivity to any of the trial drugs or their ingredients. 12.Patients who have completed participation in any other clinical trial during the past six months 13.Any other condition which the Investigator thinks may jeopardize the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief in Signs & Symptoms (pain and associated complaints) of the disease by reduction in the Northwick Park Neck Pain questionnaireTimepoint: Relief in Signs & Symptoms (pain and associated complaints) of the disease by reduction in the Northwick Park Neck Pain questionnaire after every 14 Days upto at the end of 98th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in health status by SF 36 Questionnaire(Rand-36)Timepoint: Basline and at the end of 12 weeks and follow up at the end of 2 weeks | — |
Countries
India
Contacts
Public ContactDr S K Sharma
Regional Ayurveda Research Institute for Nutritional Disorders
Outcome results
None listed